Vimarsana
Biggest News Aggregation in the World

Page 2 - Cm Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cm Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cm Life Sciences Today - Breaking & Trending Today

HYAC Stock Price | Haymaker Acquisition Corp. 4 Stock Quote (U.S.: NYSE) - Vimarsana News

HYAC Stock Price | Haymaker Acquisition Corp. 4 Stock Quote (U.S.: NYSE)

HYAC | Complete Haymaker Acquisition Corp. 4 stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Revolution to Buy EQRx in All-Stock Deal, Add $1B in Cash to Balance Sheet - Vimarsana News

Revolution to Buy EQRx in All-Stock Deal, Add $1B in Cash to Balance Sheet

Following difficult recent months for EQRx, the biotech is being bought by Revolution Medicines in an all-stock transaction that secures $1 billion in additional capital for the oncology company.

GeneDx Holdings Corp. (NASDAQ:WGS) Director Richard C. Pfenniger, Jr. Purchases 5,000 Shares - Vimarsana News

GeneDx Holdings Corp. (NASDAQ:WGS) Director Richard C. Pfenniger, Jr. Purchases 5,000 Shares

GeneDx Holdings Corp. (NASDAQ:WGS – Get Rating) Director Richard C. Pfenniger, Jr. bought 5,000 shares of the company’s stock in a transaction dated Thursday, May 18th. The shares were acquired at an average cost of $5.90 per share, with a total value of $29,500.00. Following the acquisition, the director now directly owns 5,918 shares of […]

GeneDx Holdings Corp. (NASDAQ:WGS) Director Richard C. Pfenniger, Jr. Purchases 5,000 Shares - Vimarsana News

GeneDx Holdings Corp. (NASDAQ:WGS) Director Richard C. Pfenniger, Jr. Purchases 5,000 Shares

GeneDx Holdings Corp. (NASDAQ:WGS – Get Rating) Director Richard C. Pfenniger, Jr. bought 5,000 shares of the company’s stock in a transaction dated Thursday, May 18th. The shares were acquired at an average cost of $5.90 per share, with a total value of $29,500.00. Following the acquisition, the director now directly owns 5,918 shares of […]

GeneDx (NASDAQ:WGS) & P3 Health Partners (NASDAQ:PIII) Critical Analysis - Vimarsana News

GeneDx (NASDAQ:WGS) & P3 Health Partners (NASDAQ:PIII) Critical Analysis

GeneDx (NASDAQ:WGS – Get Rating) and P3 Health Partners (NASDAQ:PIII – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, dividends and profitability. Institutional and Insider Ownership 56.0% of GeneDx shares are […]